Pelthos Therapeutics Inc. (PTHS) financial statements and ratios from SEC XBRL: revenue $16.80M (TTM), net margin -257.9%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $16.80M |
| Net Margin | -257.9% |
| Price / Sales | 2.91 |
| FCF Yield | -22.4% |
| Altman Z-Score | -0.57 (distress) |
| Sector P/E (Healthcare) | 21.7 |
PTHS overview · PTHS earnings · PTHS KPIs · PTHS investor relations · PTHS ownership · PTHS peers · PTHS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.